Table 1.
Classification | Condition |
---|---|
Naïve | Patients who received suvorexant without any history of use of drugs for insomnia (drugs used 50 days or longer before initiation of suvorexant are not considered as drugs used) |
Switching | Patients who received suvorexant after discontinuation or dose reduction of existing drug(s) for insomnia within 14 days before initiation of suvorexant |
Add-on | Patients who received suvorexant without changing the use of existing drug(s) for insomnia within 14 days before initiation of suvorexant |
Others | Patients other than the above |